WBC2016 Legacy Travel Award Deadline Extended to March 2
0 comments
by
The deadline for the WBC2016 Legacy Travel Award has been extended to March 2, 2026, to match the abstract deadline extension for the CBS CSPS CC-CRS Conference...
Abstract Deadline Extended for CBS/CSPS/CC-CRS Conference
0 comments
by
Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...
Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Integrating Morphogen releasing Microspheres into Human Induced Pluripotent Stem Cell Aggregates with Hydrogel Scaffolds to Induce Neuronal Differentiation
comments
The Willerth Lab differentiates human induced pluripotent stem cells hiPSCs into functional neurons for drug screening and therapeutics see https www...
Personalized oral dosage forms with tunable release profiles have emerged for optimal treatment of chronic diseases that require variable patterns of drug release in the treatment regimen...
Metal by-products, including metal ions, released in greater amount from metal-on-metal MM hip implants than from metal-on-polyethylene implants are a cause for concern as they can compromise the functionality and survivorship of the implants due to adverse tissue reactions 1, 2 ...
Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...
TIER 2 CANADA RESEARCH CHAIR IN CELL ENGINEERING AND BIOMANUFACTURING more
Assistant, Associate, or Full Professor in Bioprocessing and Biomanufacturing more
Research Associate in Next-Generation RNA Therapeutics at UBC more
Research Associate in Next-Generation RNA Therapeutics at UBC more
Recent Member Projects
Nathália Fernanda Sczesny: Multi-approach surface modification on Polyetheretherketone for dental implants application more
Brenden Wheeler: Implementation and Study of Standardized Condensation Synthesis Strategies for Degradable Polyester Biomaterials more
Élie Daoust: Optimization of a test bench for the evaluation of blood embolizing agents for arterial and venous applications more
Yann Bami-Chatenet: Multifunctional and injectable core-shell microspheres for cell therapy and endovascular treatments more
Recent Member Publications
Kate MacQuarrie: Smooth muscle cell-like support cells accelerate the autologous endothelialization of a polyurethane scaffold for vascular engineering more
Alma Tamunonengiofori Banigo: Bioactive Hydrogels Based on Tyramine and Maleimide Functionalized Dextran for Tissue Engineering Applications more
Alma Tamunonengiofori Banigo: Injectable hydrogels for cartilage tissue engineering: key design needs toward clinical applications more
Alma Tamunonengiofori Banigo: Hydrogel-Based Bioinks for Coaxial and Triaxial Bioprinting: A Review of Material Properties, Printing Techniques, and Applications more